Overall, the trial demonstrated that once-weekly Cagrilintide induced clinically meaningful, dose-dependent weight loss in adults with overweight or obesity, with efficacy comparable or superior to liraglutide 3.0 mg
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer a safe and potentially beneficial option for managing obesity and metabolic comorbidities in adults with inflammatory bowel disease (IBD), according to a systematic review published in Alimentary Pharmacology & Therapeutics
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
A focus on albuminuria and a new combination of antidiabetic agents
The main difference is that Mounjaros dual action sometimes creates slightly more gastrointestinal issues, though this varies by individual
Conjugated Linoleic Acid (CLA) Found in dairy and meat, CLA helps reduce body fat and maintain lean muscle